Answer
The chromogenic assay is recommended for monitoring factor VIII activity during treatment with moroctocog alfa (ReFacto AF).
Sources for this answer
- ReFacto AF 3000 IU powder and solvent for solution for injection in pre-filled syringePfizer Limited · emc · SmPC §4.2 Posology and method of administration · Version 18Document updated
Sources checked